CRISPR
New enzyme provides a powerful new tool in the CRISPR genome editing toolbox, because it can target a wider range of genetic sequences compared to Cas9 and Cas12
| 1 min read
New method could produce better seeds compared with conventional hybrid methods and shorten the production timeline by five to 10 years
| 3 min read
A new CRISPR-free tool brings gene editing power to cells' second, smaller genome—the one in their mitochondria
| 4 min read
Computational models based on deep learning predict the activities of SpCas9 variants and provide a useful guide for selecting the most appropriate one
| 2 min read
New Samplix Services offer researchers PCR-free, single-molecule target selection of genomic regions by the Xdrop™ experts
| 2 min read
Because of the urgency to get new tests, therapies, and preventions into the clinic amid a pandemic, many of these approaches are undergoing a trial by fire
| 1 min read
Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not possible
| 3 min read
New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system
| 2 min read
The platform will be applied across Axxam’s integrated discovery services, in fields such as pharmaceuticals, crop protection, animal health, and food and beverages
| 1 min read
